These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

753 related articles for article (PubMed ID: 19148464)

  • 1. Resistance to paclitaxel therapy is related with Bcl-2 expression through an estrogen receptor mediated pathway in breast cancer.
    Tabuchi Y; Matsuoka J; Gunduz M; Imada T; Ono R; Ito M; Motoki T; Yamatsuji T; Shirakawa Y; Takaoka M; Haisa M; Tanaka N; Kurebayashi J; Jordan VC; Naomoto Y
    Int J Oncol; 2009 Feb; 34(2):313-9. PubMed ID: 19148464
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Rationale for sequential tamoxifen and anticancer drugs in adjuvant setting for patients with node- and receptor-positive breast cancer.
    Kim R; Tanabe K; Emi M; Uchida Y; Osaki A; Toge T
    Int J Oncol; 2005 Apr; 26(4):1025-31. PubMed ID: 15753998
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 17 beta-estradiol-regulated expression of protein tyrosine phosphatase gamma gene in cultured human normal breast and breast cancer cells.
    Zheng J; Kulp SK; Zhang Y; Sugimoto Y; Dayton MA; Govindan MV; Brueggemeier RW; Lin YC
    Anticancer Res; 2000; 20(1A):11-9. PubMed ID: 10769629
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Antiestrogenic and DNA damaging effects induced by tamoxifen and toremifene metabolites.
    Liu X; Pisha E; Tonetti DA; Yao D; Li Y; Yao J; Burdette JE; Bolton JL
    Chem Res Toxicol; 2003 Jul; 16(7):832-7. PubMed ID: 12870885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapamycin inhibits proliferation of estrogen-receptor-positive breast cancer cells.
    Chang SB; Miron P; Miron A; Iglehart JD
    J Surg Res; 2007 Mar; 138(1):37-44. PubMed ID: 17109887
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Estrogen receptor-α directly regulates sensitivity to paclitaxel in neoadjuvant chemotherapy for breast cancer.
    Tokuda E; Seino Y; Arakawa A; Saito M; Kasumi F; Hayashi S; Yamaguchi Y
    Breast Cancer Res Treat; 2012 Jun; 133(2):427-36. PubMed ID: 21909982
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A metastatic breast tumor cell line, GI-101A, is estrogen receptor positive and responsive to estrogen but resistant to tamoxifen.
    Morrissey JJ; Raney S
    Cell Biol Int; 1998; 22(6):413-9. PubMed ID: 10328849
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of ER and VDR is not sufficient to make ER-negative MDA-MB231 breast cancer cells responsive to 1alpha-hydroxyvitamin D5.
    Peng X; Jhaveri P; Hussain-Hakimjee EA; Mehta RG
    Carcinogenesis; 2007 May; 28(5):1000-7. PubMed ID: 17130524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-proliferative effect of estrogen in breast cancer cells that re-express ERalpha is mediated by aberrant regulation of cell cycle genes.
    Moggs JG; Murphy TC; Lim FL; Moore DJ; Stuckey R; Antrobus K; Kimber I; Orphanides G
    J Mol Endocrinol; 2005 Apr; 34(2):535-51. PubMed ID: 15821115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High level expression of differentially localized BAG-1 isoforms in some oestrogen receptor-positive human breast cancers.
    Brimmell M; Burns JS; Munson P; McDonald L; O'Hare MJ; Lakhani SR; Packham G
    Br J Cancer; 1999 Nov; 81(6):1042-51. PubMed ID: 10576663
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modulation of cell cycles and apoptosis by apicidin in estrogen receptor (ER)-positive and-negative human breast cancer cells.
    Im JY; Park H; Kang KW; Choi WS; Kim HS
    Chem Biol Interact; 2008 Apr; 172(3):235-44. PubMed ID: 18313654
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Human breast cancer susceptibility to paclitaxel therapy is independent of Bcl-2 expression.
    Poelman SM; Adeyanju MO; Robertson MA; Recant WM; Karrison T; Fleming GF; Olopade OI; Conzen SD
    Clin Cancer Res; 2000 Oct; 6(10):4043-8. PubMed ID: 11051254
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 1,25-Dihydroxyvitamin D3 and all-trans-retinoic acid sensitize breast cancer cells to chemotherapy-induced cell death.
    Wang Q; Yang W; Uytingco MS; Christakos S; Wieder R
    Cancer Res; 2000 Apr; 60(7):2040-8. PubMed ID: 10766196
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differential effects of retinoic acid on the growth of isogenic metastatic and non-metastatic breast cancer cell lines and their association with distinct expression of retinoic acid receptor beta isoforms 2 and 4.
    Hayashi K; Goodison S; Urquidi V; Tarin D; Lotan R; Tahara E
    Int J Oncol; 2003 Mar; 22(3):623-9. PubMed ID: 12579317
    [TBL] [Abstract][Full Text] [Related]  

  • 15. 17Beta-estradiol induces down-regulation of Cap43/NDRG1/Drg-1, a putative differentiation-related and metastasis suppressor gene, in human breast cancer cells.
    Fotovati A; Fujii T; Yamaguchi M; Kage M; Shirouzu K; Oie S; Basaki Y; Ono M; Yamana H; Kuwano M
    Clin Cancer Res; 2006 May; 12(10):3010-8. PubMed ID: 16707596
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Concentration-dependent mitogenic and antiproliferative actions of 2-methoxyestradiol in estrogen receptor-positive human breast cancer cells.
    Liu ZJ; Zhu BT
    J Steroid Biochem Mol Biol; 2004 Mar; 88(3):265-75. PubMed ID: 15120420
    [TBL] [Abstract][Full Text] [Related]  

  • 17. IL-8 expression and its possible relationship with estrogen-receptor-negative status of breast cancer cells.
    Freund A; Chauveau C; Brouillet JP; Lucas A; Lacroix M; Licznar A; Vignon F; Lazennec G
    Oncogene; 2003 Jan; 22(2):256-65. PubMed ID: 12527894
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The vitamin A family can significantly decrease the expression of ERbeta of ERs positive breast cancer cells in the presence or absence of ER ligands and paclitaxel.
    Czeczuga-Semeniuk E; Jarzabek K; Lemancewicz D; Wołczyński S
    Gynecol Endocrinol; 2009 May; 25(5):287-93. PubMed ID: 19340624
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The effect of seal oil on paclitaxel induced cytotoxicity and apoptosis in breast carcinoma MCF-7 and MDA-MB-231 cell lines.
    Wang Z; Butt K; Wang L; Liu H
    Nutr Cancer; 2007; 58(2):230-8. PubMed ID: 17640170
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of a human breast cancer cell line, MCF-7/RU58R-1, resistant to the pure antiestrogen RU 58,668.
    Fog CK; Christensen IJ; Lykkesfeldt AE
    Breast Cancer Res Treat; 2005 May; 91(2):133-44. PubMed ID: 15868441
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 38.